Trial Profile
A Study to Evaluate the Impact of Whole Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma Treated With 131 I-Metaiodobenzylguanidine (MIBG)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2016
Price :
$35
*
At a glance
- Drugs Iobenguane (Primary)
- Indications Neuroblastoma
- Focus Adverse reactions; Therapeutic Use
- 05 Jul 2016 New trial record